Search Results - "Shoukfeh, Rajaa"

New-Onset Psoriasis Induced by Durvalumab by Shoukfeh, Rajaa, Yassine, Reem, Turk, Dilara, Moossavi, Meena, Nofzinger, April

“…Durvalumab is an immune checkpoint inhibitor (ICI) belonging to the anti-programmed death-ligand 1 (PD-L1) class, and it is used in the treatment of various…”
Get full text

A review of the efficacy of popular eye cream ingredients by Hamie, Hanin, Yassine, Reem, Shoukfeh, Rajaa, Turk, Dilara, Huq, Farhan, Moossavi, Meena

“…Due to the periorbital region's high susceptibility to damage from external factors, along with its tendency to demonstrate early signs of aging, periorbital…”
Get full text

52787 TikTok Skincare Trends and their Clinical Evidence by Turk, Derya, Shoukfeh, Rajaa, Turk, Dilara, Adlam, Taylor, Potts, Geoffrey

Get full text

Research With Refugees and Vulnerable Populations in a Post-COVID World: Challenges and Opportunities by Saad, Bassem, George, Sophie A., Bazzi, Celine, Gorski, Kathleen, Abou-Rass, Noor, Shoukfeh, Rajaa, Javanbakht, Arash

“…At the Stress, Trauma and Anxiety Research Clinic (STARC) at Wayne State University in Detroit, we are currently amid data collection for a longitudinal…”
Get full text

Cutaneous metastasis of gastric cancer is associated with a poor prognosis: a systematic review by Azam, Mustafa, Shoukfeh, Rajaa, Fried, Sarah, Rehman, Sheema, Rehman, Wasey, Rehman, Rafey, Mehregan, Darius

Get full text

Assessing the Trends of Outcome Measures and Quality of Life Instruments in Vitiligo: A Systematic Review by Maghfour, Jalal, Shoukfeh, Rajaa, Hamzavi, Iltefat H, Ezzedine, Khaled, Mohammad, Tasneem F

Get full text

Misinformation about Monkeypox on TikTok by Meyer, Madison, Shoukfeh, Rajaa, Turk, Dilara, Potts, Geoffrey

“…TikTok is the newest and the most popular form of social media for young global audiences. Healthcare professionals can present medical information to all…”
Get more information

New-Onset Psoriasis Induced by Durvalumab by Shoukfeh, Rajaa, Yassine, Reem, Turk, Dilara, Moossavi, Meena, Nofzinger, April

“…Durvalumab is an immune checkpoint inhibitor (ICI) belonging to the anti-programmed death-ligand 1 (PD-L1) class, and it is used in the treatment of various…”
Get full text